Dr. Priyom Bose

Dr. Priyom Bose

Feature Writer

B.Sc. Botany, M.Sc. Plant Biology and Biotechnology, Ph.D. Plant Biology and Biotechnology

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Articles from Priyom

The relationship between COVID-19 certification and vaccine uptake

The relationship between COVID-19 certification and vaccine uptake

COVID-19 vaccination induces transient increase in cellular and antibody responses to S1 antigenic sequence

COVID-19 vaccination induces transient increase in cellular and antibody responses to S1 antigenic sequence

Research reveals components of Sinbis virus ribonucleoproteins

Research reveals components of Sinbis virus ribonucleoproteins

A new bacterial two-hybrid assay to study SARS-CoV-2 interactome

A new bacterial two-hybrid assay to study SARS-CoV-2 interactome

SARS-CoV-2 immune responses in nursing home residents after full vaccination with Pfizer-BioNTech COVID-19 vaccine

SARS-CoV-2 immune responses in nursing home residents after full vaccination with Pfizer-BioNTech COVID-19 vaccine

Plasmonic sensing of isothermally amplified nucleic acids and single-molecule detection of SARS-CoV-2

Plasmonic sensing of isothermally amplified nucleic acids and single-molecule detection of SARS-CoV-2

High fat diet exacerbates Alzheimer's disease in mouse model

High fat diet exacerbates Alzheimer's disease in mouse model

BNT162b2 COVID vaccine humoral response substantially reduced after 6 months

BNT162b2 COVID vaccine humoral response substantially reduced after 6 months

SARS-CoV-2 evolution promoted by long-term infection in patient with B cell depletion

SARS-CoV-2 evolution promoted by long-term infection in patient with B cell depletion

Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.